TY - JOUR T1 - Obstetric antiphospholipid syndrome JF - Lupus Science & Medicine DO - 10.1136/lupus-2016-000197 VL - 5 IS - 1 SP - e000197 AU - Aleksandra Antovic AU - Maria Sennström AU - Katarina Bremme AU - Elisabet Svenungsson Y1 - 2018/09/01 UR - http://lupus.bmj.com/content/5/1/e000197.abstract N2 - The present clinical and laboratory classification criteria for antiphospholipid syndrome (APS) were established in Sydney, Australia, in 2006. In this review, we focus on the obstetric subset of APS (OAPS), defined by persistent positivity for antiphospholipid antibodies together with either early recurrent pregnancy loss, early fetal death, stillbirth or premature birth <34 gestational weeks due to pre-eclampsia, eclampsia and placental insufficiency. It is important to diagnose these cases since most women suffering from OAPS can, when given appropriate treatment, have successful pregnancies. Furthermore, patients with OAPS may, depending on the antibody profile, be at enhanced risk of thrombotic events later in life. We present an update on the present knowledge of possible underlying pathogenesis, risk factors and risk estimations for adverse pregnancy outcomes before and during pregnancy, current treatment concepts, and long-term outcomes for women with OAPS and their children. ER -